nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—CYP2D6—Fingolimod—multiple sclerosis	0.0965	0.199	CbGbCtD
Doxazosin—ABCB1—Methylprednisolone—multiple sclerosis	0.066	0.136	CbGbCtD
Doxazosin—CYP2C19—Prednisone—multiple sclerosis	0.0496	0.102	CbGbCtD
Doxazosin—ABCB1—Mitoxantrone—multiple sclerosis	0.0482	0.0993	CbGbCtD
Doxazosin—ABCB1—Betamethasone—multiple sclerosis	0.0429	0.0885	CbGbCtD
Doxazosin—ABCB1—Prednisolone—multiple sclerosis	0.0424	0.0873	CbGbCtD
Doxazosin—ABCB1—Prednisone—multiple sclerosis	0.04	0.0824	CbGbCtD
Doxazosin—CYP2C19—Dexamethasone—multiple sclerosis	0.0309	0.0638	CbGbCtD
Doxazosin—ABCB1—Dexamethasone—multiple sclerosis	0.025	0.0515	CbGbCtD
Doxazosin—CYP2D6—Dexamethasone—multiple sclerosis	0.0235	0.0485	CbGbCtD
Doxazosin—ABCB1—Methotrexate—multiple sclerosis	0.0201	0.0414	CbGbCtD
Doxazosin—KCNH7—nervous system—multiple sclerosis	0.00308	0.0641	CbGeAlD
Doxazosin—ADRA2A—peripheral nervous system—multiple sclerosis	0.00302	0.0631	CbGeAlD
Doxazosin—KCNH7—central nervous system—multiple sclerosis	0.00296	0.0617	CbGeAlD
Doxazosin—KCNH7—cerebellum—multiple sclerosis	0.00289	0.0604	CbGeAlD
Doxazosin—KCNH7—brain—multiple sclerosis	0.00235	0.049	CbGeAlD
Doxazosin—KCNH6—nervous system—multiple sclerosis	0.00219	0.0457	CbGeAlD
Doxazosin—KCNH6—central nervous system—multiple sclerosis	0.00211	0.044	CbGeAlD
Doxazosin—KCNH6—brain—multiple sclerosis	0.00168	0.0349	CbGeAlD
Doxazosin—ADRA1A—brainstem—multiple sclerosis	0.00133	0.0278	CbGeAlD
Doxazosin—ADRA1B—nervous system—multiple sclerosis	0.00124	0.0259	CbGeAlD
Doxazosin—ADRA1D—nervous system—multiple sclerosis	0.00121	0.0253	CbGeAlD
Doxazosin—ADRA1B—central nervous system—multiple sclerosis	0.0012	0.0249	CbGeAlD
Doxazosin—ORM1—spinal cord—multiple sclerosis	0.00119	0.0247	CbGeAlD
Doxazosin—ADRA1D—central nervous system—multiple sclerosis	0.00117	0.0244	CbGeAlD
Doxazosin—ORM1—nervous system—multiple sclerosis	0.001	0.0209	CbGeAlD
Doxazosin—ORM1—central nervous system—multiple sclerosis	0.000963	0.0201	CbGeAlD
Doxazosin—ADRA1B—brain—multiple sclerosis	0.000949	0.0198	CbGeAlD
Doxazosin—ADRA1D—brain—multiple sclerosis	0.000928	0.0194	CbGeAlD
Doxazosin—KCNH2—medulla oblongata—multiple sclerosis	0.000896	0.0187	CbGeAlD
Doxazosin—KCNH2—midbrain—multiple sclerosis	0.000819	0.0171	CbGeAlD
Doxazosin—KCNH2—spinal cord—multiple sclerosis	0.000799	0.0167	CbGeAlD
Doxazosin—CYP2D6—brainstem—multiple sclerosis	0.000784	0.0163	CbGeAlD
Doxazosin—ADRA2A—medulla oblongata—multiple sclerosis	0.000706	0.0147	CbGeAlD
Doxazosin—ADRA1A—nervous system—multiple sclerosis	0.000697	0.0145	CbGeAlD
Doxazosin—KCNH2—nervous system—multiple sclerosis	0.000674	0.014	CbGeAlD
Doxazosin—ADRA1A—central nervous system—multiple sclerosis	0.000671	0.014	CbGeAlD
Doxazosin—ADRA1A—cerebellum—multiple sclerosis	0.000656	0.0137	CbGeAlD
Doxazosin—KCNH2—central nervous system—multiple sclerosis	0.000648	0.0135	CbGeAlD
Doxazosin—ADRA2A—midbrain—multiple sclerosis	0.000645	0.0134	CbGeAlD
Doxazosin—KCNH2—cerebellum—multiple sclerosis	0.000634	0.0132	CbGeAlD
Doxazosin—ADRA2A—spinal cord—multiple sclerosis	0.000629	0.0131	CbGeAlD
Doxazosin—ABCB1—retina—multiple sclerosis	0.000544	0.0113	CbGeAlD
Doxazosin—ADRA1A—brain—multiple sclerosis	0.000533	0.0111	CbGeAlD
Doxazosin—ADRA2A—nervous system—multiple sclerosis	0.00053	0.0111	CbGeAlD
Doxazosin—KCNH2—brain—multiple sclerosis	0.000515	0.0107	CbGeAlD
Doxazosin—ADRA2A—central nervous system—multiple sclerosis	0.000511	0.0106	CbGeAlD
Doxazosin—ADRA2A—cerebellum—multiple sclerosis	0.000499	0.0104	CbGeAlD
Doxazosin—CYP2D6—nervous system—multiple sclerosis	0.000411	0.00856	CbGeAlD
Doxazosin—ADRA2A—brain—multiple sclerosis	0.000405	0.00845	CbGeAlD
Doxazosin—CYP2D6—central nervous system—multiple sclerosis	0.000395	0.00825	CbGeAlD
Doxazosin—ABCB1—medulla oblongata—multiple sclerosis	0.000393	0.0082	CbGeAlD
Doxazosin—CYP2D6—cerebellum—multiple sclerosis	0.000387	0.00806	CbGeAlD
Doxazosin—ABCB1—midbrain—multiple sclerosis	0.000359	0.00749	CbGeAlD
Doxazosin—ABCB1—spinal cord—multiple sclerosis	0.000351	0.00731	CbGeAlD
Doxazosin—CYP2D6—brain—multiple sclerosis	0.000314	0.00655	CbGeAlD
Doxazosin—Dry mouth—Triamcinolone—multiple sclerosis	0.000301	0.000849	CcSEcCtD
Doxazosin—Conjunctivitis—Methotrexate—multiple sclerosis	0.000297	0.000838	CcSEcCtD
Doxazosin—Confusional state—Methylprednisolone—multiple sclerosis	0.000297	0.000837	CcSEcCtD
Doxazosin—Malaise—Dexamethasone—multiple sclerosis	0.000296	0.000834	CcSEcCtD
Doxazosin—Malaise—Betamethasone—multiple sclerosis	0.000296	0.000834	CcSEcCtD
Doxazosin—ABCB1—nervous system—multiple sclerosis	0.000295	0.00616	CbGeAlD
Doxazosin—Oedema—Triamcinolone—multiple sclerosis	0.000295	0.000832	CcSEcCtD
Doxazosin—Vertigo—Dexamethasone—multiple sclerosis	0.000295	0.000831	CcSEcCtD
Doxazosin—Vertigo—Betamethasone—multiple sclerosis	0.000295	0.000831	CcSEcCtD
Doxazosin—Syncope—Betamethasone—multiple sclerosis	0.000294	0.00083	CcSEcCtD
Doxazosin—Syncope—Dexamethasone—multiple sclerosis	0.000294	0.00083	CcSEcCtD
Doxazosin—Arrhythmia—Prednisone—multiple sclerosis	0.000293	0.000827	CcSEcCtD
Doxazosin—Infection—Triamcinolone—multiple sclerosis	0.000293	0.000827	CcSEcCtD
Doxazosin—Sweating—Methotrexate—multiple sclerosis	0.000293	0.000826	CcSEcCtD
Doxazosin—Infection—Methylprednisolone—multiple sclerosis	0.000292	0.000825	CcSEcCtD
Doxazosin—Haematuria—Methotrexate—multiple sclerosis	0.000291	0.000822	CcSEcCtD
Doxazosin—Shock—Triamcinolone—multiple sclerosis	0.00029	0.000819	CcSEcCtD
Doxazosin—Insomnia—Prednisolone—multiple sclerosis	0.00029	0.000819	CcSEcCtD
Doxazosin—Alopecia—Prednisone—multiple sclerosis	0.00029	0.000818	CcSEcCtD
Doxazosin—Shock—Methylprednisolone—multiple sclerosis	0.00029	0.000817	CcSEcCtD
Doxazosin—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000288	0.000813	CcSEcCtD
Doxazosin—Loss of consciousness—Betamethasone—multiple sclerosis	0.000288	0.000813	CcSEcCtD
Doxazosin—Epistaxis—Methotrexate—multiple sclerosis	0.000288	0.000813	CcSEcCtD
Doxazosin—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000288	0.000813	CcSEcCtD
Doxazosin—Paraesthesia—Prednisolone—multiple sclerosis	0.000288	0.000813	CcSEcCtD
Doxazosin—Tachycardia—Triamcinolone—multiple sclerosis	0.000288	0.000812	CcSEcCtD
Doxazosin—Mental disorder—Prednisone—multiple sclerosis	0.000287	0.000811	CcSEcCtD
Doxazosin—Nausea—Azathioprine—multiple sclerosis	0.000287	0.000811	CcSEcCtD
Doxazosin—Tachycardia—Methylprednisolone—multiple sclerosis	0.000287	0.00081	CcSEcCtD
Doxazosin—Skin disorder—Methylprednisolone—multiple sclerosis	0.000286	0.000807	CcSEcCtD
Doxazosin—Malnutrition—Prednisone—multiple sclerosis	0.000286	0.000806	CcSEcCtD
Doxazosin—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000285	0.000805	CcSEcCtD
Doxazosin—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000285	0.000803	CcSEcCtD
Doxazosin—ABCB1—central nervous system—multiple sclerosis	0.000284	0.00593	CbGeAlD
Doxazosin—Convulsion—Betamethasone—multiple sclerosis	0.000284	0.000802	CcSEcCtD
Doxazosin—Convulsion—Dexamethasone—multiple sclerosis	0.000284	0.000802	CcSEcCtD
Doxazosin—Hypertension—Betamethasone—multiple sclerosis	0.000283	0.000799	CcSEcCtD
Doxazosin—Hypertension—Dexamethasone—multiple sclerosis	0.000283	0.000799	CcSEcCtD
Doxazosin—Asthenia—Mitoxantrone—multiple sclerosis	0.000281	0.000791	CcSEcCtD
Doxazosin—Myalgia—Dexamethasone—multiple sclerosis	0.000279	0.000788	CcSEcCtD
Doxazosin—Myalgia—Betamethasone—multiple sclerosis	0.000279	0.000788	CcSEcCtD
Doxazosin—Anxiety—Betamethasone—multiple sclerosis	0.000278	0.000785	CcSEcCtD
Doxazosin—Anxiety—Dexamethasone—multiple sclerosis	0.000278	0.000785	CcSEcCtD
Doxazosin—ABCB1—cerebellum—multiple sclerosis	0.000278	0.0058	CbGeAlD
Doxazosin—Discomfort—Betamethasone—multiple sclerosis	0.000276	0.000778	CcSEcCtD
Doxazosin—Discomfort—Dexamethasone—multiple sclerosis	0.000276	0.000778	CcSEcCtD
Doxazosin—Hypotension—Methylprednisolone—multiple sclerosis	0.000275	0.000776	CcSEcCtD
Doxazosin—Pain—Prednisolone—multiple sclerosis	0.000274	0.000774	CcSEcCtD
Doxazosin—Hepatitis—Methotrexate—multiple sclerosis	0.000274	0.000774	CcSEcCtD
Doxazosin—Pharyngitis—Methotrexate—multiple sclerosis	0.000272	0.000768	CcSEcCtD
Doxazosin—Vision blurred—Prednisone—multiple sclerosis	0.000269	0.000759	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000269	0.000758	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000268	0.000757	CcSEcCtD
Doxazosin—Oedema—Dexamethasone—multiple sclerosis	0.000268	0.000755	CcSEcCtD
Doxazosin—Oedema—Betamethasone—multiple sclerosis	0.000268	0.000755	CcSEcCtD
Doxazosin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000268	0.000755	CcSEcCtD
Doxazosin—Insomnia—Triamcinolone—multiple sclerosis	0.000267	0.000753	CcSEcCtD
Doxazosin—Insomnia—Methylprednisolone—multiple sclerosis	0.000266	0.000751	CcSEcCtD
Doxazosin—Infection—Dexamethasone—multiple sclerosis	0.000266	0.00075	CcSEcCtD
Doxazosin—Infection—Betamethasone—multiple sclerosis	0.000266	0.00075	CcSEcCtD
Doxazosin—Ill-defined disorder—Prednisone—multiple sclerosis	0.000265	0.000748	CcSEcCtD
Doxazosin—Paraesthesia—Triamcinolone—multiple sclerosis	0.000265	0.000747	CcSEcCtD
Doxazosin—Feeling abnormal—Prednisolone—multiple sclerosis	0.000264	0.000746	CcSEcCtD
Doxazosin—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000264	0.000746	CcSEcCtD
Doxazosin—Visual impairment—Methotrexate—multiple sclerosis	0.000264	0.000746	CcSEcCtD
Doxazosin—Shock—Betamethasone—multiple sclerosis	0.000263	0.000743	CcSEcCtD
Doxazosin—Shock—Dexamethasone—multiple sclerosis	0.000263	0.000743	CcSEcCtD
Doxazosin—Dyspnoea—Triamcinolone—multiple sclerosis	0.000263	0.000742	CcSEcCtD
Doxazosin—Agitation—Prednisone—multiple sclerosis	0.000263	0.000741	CcSEcCtD
Doxazosin—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000262	0.000739	CcSEcCtD
Doxazosin—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000262	0.000739	CcSEcCtD
Doxazosin—Tachycardia—Betamethasone—multiple sclerosis	0.000261	0.000737	CcSEcCtD
Doxazosin—Tachycardia—Dexamethasone—multiple sclerosis	0.000261	0.000737	CcSEcCtD
Doxazosin—Dyspepsia—Triamcinolone—multiple sclerosis	0.00026	0.000733	CcSEcCtD
Doxazosin—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000259	0.000731	CcSEcCtD
Doxazosin—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000259	0.00073	CcSEcCtD
Doxazosin—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000259	0.00073	CcSEcCtD
Doxazosin—Malaise—Prednisone—multiple sclerosis	0.000258	0.000727	CcSEcCtD
Doxazosin—Vertigo—Prednisone—multiple sclerosis	0.000257	0.000724	CcSEcCtD
Doxazosin—Eye disorder—Methotrexate—multiple sclerosis	0.000256	0.000723	CcSEcCtD
Doxazosin—Syncope—Prednisone—multiple sclerosis	0.000256	0.000723	CcSEcCtD
Doxazosin—Tinnitus—Methotrexate—multiple sclerosis	0.000256	0.000721	CcSEcCtD
Doxazosin—Anorexia—Dexamethasone—multiple sclerosis	0.000255	0.00072	CcSEcCtD
Doxazosin—Anorexia—Betamethasone—multiple sclerosis	0.000255	0.00072	CcSEcCtD
Doxazosin—Urticaria—Prednisolone—multiple sclerosis	0.000255	0.000719	CcSEcCtD
Doxazosin—Fatigue—Triamcinolone—multiple sclerosis	0.000254	0.000718	CcSEcCtD
Doxazosin—Fatigue—Methylprednisolone—multiple sclerosis	0.000254	0.000716	CcSEcCtD
Doxazosin—Pain—Triamcinolone—multiple sclerosis	0.000252	0.000712	CcSEcCtD
Doxazosin—Loss of consciousness—Prednisone—multiple sclerosis	0.000251	0.000708	CcSEcCtD
Doxazosin—Hypotension—Dexamethasone—multiple sclerosis	0.00025	0.000706	CcSEcCtD
Doxazosin—Hypotension—Betamethasone—multiple sclerosis	0.00025	0.000706	CcSEcCtD
Doxazosin—Vomiting—Mitoxantrone—multiple sclerosis	0.000249	0.000701	CcSEcCtD
Doxazosin—Convulsion—Prednisone—multiple sclerosis	0.000248	0.000698	CcSEcCtD
Doxazosin—Hypertension—Prednisone—multiple sclerosis	0.000247	0.000696	CcSEcCtD
Doxazosin—Rash—Mitoxantrone—multiple sclerosis	0.000247	0.000696	CcSEcCtD
Doxazosin—Dermatitis—Mitoxantrone—multiple sclerosis	0.000246	0.000695	CcSEcCtD
Doxazosin—Chills—Methotrexate—multiple sclerosis	0.000246	0.000694	CcSEcCtD
Doxazosin—Headache—Mitoxantrone—multiple sclerosis	0.000245	0.000691	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000244	0.000688	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000244	0.000688	CcSEcCtD
Doxazosin—Myalgia—Prednisone—multiple sclerosis	0.000243	0.000686	CcSEcCtD
Doxazosin—Arthralgia—Prednisone—multiple sclerosis	0.000243	0.000686	CcSEcCtD
Doxazosin—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000243	0.000686	CcSEcCtD
Doxazosin—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000243	0.000684	CcSEcCtD
Doxazosin—Anxiety—Prednisone—multiple sclerosis	0.000242	0.000684	CcSEcCtD
Doxazosin—Alopecia—Methotrexate—multiple sclerosis	0.000242	0.000684	CcSEcCtD
Doxazosin—Insomnia—Dexamethasone—multiple sclerosis	0.000242	0.000683	CcSEcCtD
Doxazosin—Insomnia—Betamethasone—multiple sclerosis	0.000242	0.000683	CcSEcCtD
Doxazosin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000241	0.000679	CcSEcCtD
Doxazosin—Paraesthesia—Dexamethasone—multiple sclerosis	0.00024	0.000678	CcSEcCtD
Doxazosin—Paraesthesia—Betamethasone—multiple sclerosis	0.00024	0.000678	CcSEcCtD
Doxazosin—Discomfort—Prednisone—multiple sclerosis	0.00024	0.000678	CcSEcCtD
Doxazosin—Mental disorder—Methotrexate—multiple sclerosis	0.00024	0.000678	CcSEcCtD
Doxazosin—Malnutrition—Methotrexate—multiple sclerosis	0.000239	0.000673	CcSEcCtD
Doxazosin—Hypersensitivity—Prednisolone—multiple sclerosis	0.000236	0.000667	CcSEcCtD
Doxazosin—Dyspepsia—Dexamethasone—multiple sclerosis	0.000236	0.000665	CcSEcCtD
Doxazosin—Dyspepsia—Betamethasone—multiple sclerosis	0.000236	0.000665	CcSEcCtD
Doxazosin—Urticaria—Triamcinolone—multiple sclerosis	0.000234	0.000661	CcSEcCtD
Doxazosin—Urticaria—Methylprednisolone—multiple sclerosis	0.000234	0.00066	CcSEcCtD
Doxazosin—Dysgeusia—Methotrexate—multiple sclerosis	0.000234	0.000659	CcSEcCtD
Doxazosin—Body temperature increased—Triamcinolone—multiple sclerosis	0.000233	0.000658	CcSEcCtD
Doxazosin—Oedema—Prednisone—multiple sclerosis	0.000233	0.000658	CcSEcCtD
Doxazosin—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000233	0.000656	CcSEcCtD
Doxazosin—Decreased appetite—Betamethasone—multiple sclerosis	0.000233	0.000656	CcSEcCtD
Doxazosin—Decreased appetite—Dexamethasone—multiple sclerosis	0.000233	0.000656	CcSEcCtD
Doxazosin—Nausea—Mitoxantrone—multiple sclerosis	0.000232	0.000655	CcSEcCtD
Doxazosin—Infection—Prednisone—multiple sclerosis	0.000232	0.000653	CcSEcCtD
Doxazosin—Back pain—Methotrexate—multiple sclerosis	0.000231	0.000651	CcSEcCtD
Doxazosin—Fatigue—Dexamethasone—multiple sclerosis	0.000231	0.000651	CcSEcCtD
Doxazosin—Fatigue—Betamethasone—multiple sclerosis	0.000231	0.000651	CcSEcCtD
Doxazosin—Shock—Prednisone—multiple sclerosis	0.000229	0.000647	CcSEcCtD
Doxazosin—Pain—Dexamethasone—multiple sclerosis	0.000229	0.000646	CcSEcCtD
Doxazosin—Pain—Betamethasone—multiple sclerosis	0.000229	0.000646	CcSEcCtD
Doxazosin—Tachycardia—Prednisone—multiple sclerosis	0.000228	0.000642	CcSEcCtD
Doxazosin—Skin disorder—Prednisone—multiple sclerosis	0.000226	0.000639	CcSEcCtD
Doxazosin—ABCB1—brain—multiple sclerosis	0.000226	0.00471	CbGeAlD
Doxazosin—Hyperhidrosis—Prednisone—multiple sclerosis	0.000225	0.000636	CcSEcCtD
Doxazosin—Vision blurred—Methotrexate—multiple sclerosis	0.000225	0.000635	CcSEcCtD
Doxazosin—Anorexia—Prednisone—multiple sclerosis	0.000222	0.000627	CcSEcCtD
Doxazosin—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000222	0.000625	CcSEcCtD
Doxazosin—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000221	0.000622	CcSEcCtD
Doxazosin—Feeling abnormal—Betamethasone—multiple sclerosis	0.000221	0.000622	CcSEcCtD
Doxazosin—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000219	0.000618	CcSEcCtD
Doxazosin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000219	0.000618	CcSEcCtD
Doxazosin—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000217	0.000613	CcSEcCtD
Doxazosin—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000217	0.000612	CcSEcCtD
Doxazosin—Malaise—Methotrexate—multiple sclerosis	0.000215	0.000607	CcSEcCtD
Doxazosin—Vertigo—Methotrexate—multiple sclerosis	0.000214	0.000605	CcSEcCtD
Doxazosin—Leukopenia—Methotrexate—multiple sclerosis	0.000214	0.000603	CcSEcCtD
Doxazosin—Urticaria—Dexamethasone—multiple sclerosis	0.000213	0.0006	CcSEcCtD
Doxazosin—Urticaria—Betamethasone—multiple sclerosis	0.000213	0.0006	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000212	0.000599	CcSEcCtD
Doxazosin—Dizziness—Prednisolone—multiple sclerosis	0.000212	0.000598	CcSEcCtD
Doxazosin—Asthenia—Triamcinolone—multiple sclerosis	0.000212	0.000597	CcSEcCtD
Doxazosin—Abdominal pain—Betamethasone—multiple sclerosis	0.000212	0.000597	CcSEcCtD
Doxazosin—Body temperature increased—Dexamethasone—multiple sclerosis	0.000212	0.000597	CcSEcCtD
Doxazosin—Body temperature increased—Betamethasone—multiple sclerosis	0.000212	0.000597	CcSEcCtD
Doxazosin—Abdominal pain—Dexamethasone—multiple sclerosis	0.000212	0.000597	CcSEcCtD
Doxazosin—Asthenia—Methylprednisolone—multiple sclerosis	0.000211	0.000596	CcSEcCtD
Doxazosin—Insomnia—Prednisone—multiple sclerosis	0.000211	0.000595	CcSEcCtD
Doxazosin—Paraesthesia—Prednisone—multiple sclerosis	0.000209	0.000591	CcSEcCtD
Doxazosin—Pruritus—Triamcinolone—multiple sclerosis	0.000209	0.000589	CcSEcCtD
Doxazosin—Cough—Methotrexate—multiple sclerosis	0.000208	0.000588	CcSEcCtD
Doxazosin—Pruritus—Methylprednisolone—multiple sclerosis	0.000208	0.000588	CcSEcCtD
Doxazosin—Convulsion—Methotrexate—multiple sclerosis	0.000207	0.000584	CcSEcCtD
Doxazosin—Dyspepsia—Prednisone—multiple sclerosis	0.000205	0.000579	CcSEcCtD
Doxazosin—Myalgia—Methotrexate—multiple sclerosis	0.000203	0.000573	CcSEcCtD
Doxazosin—Arthralgia—Methotrexate—multiple sclerosis	0.000203	0.000573	CcSEcCtD
Doxazosin—Chest pain—Methotrexate—multiple sclerosis	0.000203	0.000573	CcSEcCtD
Doxazosin—Decreased appetite—Prednisone—multiple sclerosis	0.000203	0.000572	CcSEcCtD
Doxazosin—Rash—Prednisolone—multiple sclerosis	0.000202	0.000571	CcSEcCtD
Doxazosin—Dermatitis—Prednisolone—multiple sclerosis	0.000202	0.00057	CcSEcCtD
Doxazosin—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000201	0.000568	CcSEcCtD
Doxazosin—Fatigue—Prednisone—multiple sclerosis	0.000201	0.000567	CcSEcCtD
Doxazosin—Headache—Prednisolone—multiple sclerosis	0.000201	0.000567	CcSEcCtD
Doxazosin—Discomfort—Methotrexate—multiple sclerosis	0.000201	0.000566	CcSEcCtD
Doxazosin—Constipation—Prednisone—multiple sclerosis	0.000199	0.000562	CcSEcCtD
Doxazosin—Confusional state—Methotrexate—multiple sclerosis	0.000196	0.000554	CcSEcCtD
Doxazosin—Dizziness—Triamcinolone—multiple sclerosis	0.000195	0.00055	CcSEcCtD
Doxazosin—Dizziness—Methylprednisolone—multiple sclerosis	0.000195	0.000549	CcSEcCtD
Doxazosin—Infection—Methotrexate—multiple sclerosis	0.000194	0.000546	CcSEcCtD
Doxazosin—Feeling abnormal—Prednisone—multiple sclerosis	0.000192	0.000542	CcSEcCtD
Doxazosin—Asthenia—Dexamethasone—multiple sclerosis	0.000192	0.000542	CcSEcCtD
Doxazosin—Asthenia—Betamethasone—multiple sclerosis	0.000192	0.000542	CcSEcCtD
Doxazosin—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000191	0.000538	CcSEcCtD
Doxazosin—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000191	0.000538	CcSEcCtD
Doxazosin—Nausea—Prednisolone—multiple sclerosis	0.000191	0.000538	CcSEcCtD
Doxazosin—Pruritus—Dexamethasone—multiple sclerosis	0.000189	0.000534	CcSEcCtD
Doxazosin—Pruritus—Betamethasone—multiple sclerosis	0.000189	0.000534	CcSEcCtD
Doxazosin—Skin disorder—Methotrexate—multiple sclerosis	0.000189	0.000534	CcSEcCtD
Doxazosin—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000188	0.000531	CcSEcCtD
Doxazosin—Vomiting—Triamcinolone—multiple sclerosis	0.000188	0.000529	CcSEcCtD
Doxazosin—Vomiting—Methylprednisolone—multiple sclerosis	0.000187	0.000528	CcSEcCtD
Doxazosin—Rash—Triamcinolone—multiple sclerosis	0.000186	0.000525	CcSEcCtD
Doxazosin—Dermatitis—Triamcinolone—multiple sclerosis	0.000186	0.000524	CcSEcCtD
Doxazosin—Anorexia—Methotrexate—multiple sclerosis	0.000186	0.000524	CcSEcCtD
Doxazosin—Rash—Methylprednisolone—multiple sclerosis	0.000186	0.000524	CcSEcCtD
Doxazosin—Dermatitis—Methylprednisolone—multiple sclerosis	0.000185	0.000523	CcSEcCtD
Doxazosin—Urticaria—Prednisone—multiple sclerosis	0.000185	0.000522	CcSEcCtD
Doxazosin—Headache—Triamcinolone—multiple sclerosis	0.000185	0.000521	CcSEcCtD
Doxazosin—Headache—Methylprednisolone—multiple sclerosis	0.000184	0.00052	CcSEcCtD
Doxazosin—Abdominal pain—Prednisone—multiple sclerosis	0.000184	0.00052	CcSEcCtD
Doxazosin—Body temperature increased—Prednisone—multiple sclerosis	0.000184	0.00052	CcSEcCtD
Doxazosin—Diarrhoea—Dexamethasone—multiple sclerosis	0.000183	0.000517	CcSEcCtD
Doxazosin—Diarrhoea—Betamethasone—multiple sclerosis	0.000183	0.000517	CcSEcCtD
Doxazosin—Hypotension—Methotrexate—multiple sclerosis	0.000182	0.000514	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000178	0.000501	CcSEcCtD
Doxazosin—Dizziness—Dexamethasone—multiple sclerosis	0.000177	0.000499	CcSEcCtD
Doxazosin—Dizziness—Betamethasone—multiple sclerosis	0.000177	0.000499	CcSEcCtD
Doxazosin—Insomnia—Methotrexate—multiple sclerosis	0.000176	0.000497	CcSEcCtD
Doxazosin—Nausea—Triamcinolone—multiple sclerosis	0.000175	0.000494	CcSEcCtD
Doxazosin—Paraesthesia—Methotrexate—multiple sclerosis	0.000175	0.000494	CcSEcCtD
Doxazosin—Nausea—Methylprednisolone—multiple sclerosis	0.000175	0.000493	CcSEcCtD
Doxazosin—Dyspnoea—Methotrexate—multiple sclerosis	0.000174	0.00049	CcSEcCtD
Doxazosin—Somnolence—Methotrexate—multiple sclerosis	0.000173	0.000489	CcSEcCtD
Doxazosin—Hypersensitivity—Prednisone—multiple sclerosis	0.000172	0.000485	CcSEcCtD
Doxazosin—Dyspepsia—Methotrexate—multiple sclerosis	0.000172	0.000484	CcSEcCtD
Doxazosin—Vomiting—Dexamethasone—multiple sclerosis	0.00017	0.00048	CcSEcCtD
Doxazosin—Vomiting—Betamethasone—multiple sclerosis	0.00017	0.00048	CcSEcCtD
Doxazosin—Decreased appetite—Methotrexate—multiple sclerosis	0.000169	0.000478	CcSEcCtD
Doxazosin—Rash—Betamethasone—multiple sclerosis	0.000169	0.000476	CcSEcCtD
Doxazosin—Rash—Dexamethasone—multiple sclerosis	0.000169	0.000476	CcSEcCtD
Doxazosin—Dermatitis—Dexamethasone—multiple sclerosis	0.000169	0.000476	CcSEcCtD
Doxazosin—Dermatitis—Betamethasone—multiple sclerosis	0.000169	0.000476	CcSEcCtD
Doxazosin—Fatigue—Methotrexate—multiple sclerosis	0.000168	0.000474	CcSEcCtD
Doxazosin—Headache—Dexamethasone—multiple sclerosis	0.000168	0.000473	CcSEcCtD
Doxazosin—Headache—Betamethasone—multiple sclerosis	0.000168	0.000473	CcSEcCtD
Doxazosin—Asthenia—Prednisone—multiple sclerosis	0.000167	0.000472	CcSEcCtD
Doxazosin—Pain—Methotrexate—multiple sclerosis	0.000167	0.00047	CcSEcCtD
Doxazosin—Pruritus—Prednisone—multiple sclerosis	0.000165	0.000465	CcSEcCtD
Doxazosin—Feeling abnormal—Methotrexate—multiple sclerosis	0.000161	0.000453	CcSEcCtD
Doxazosin—Diarrhoea—Prednisone—multiple sclerosis	0.00016	0.00045	CcSEcCtD
Doxazosin—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000159	0.000449	CcSEcCtD
Doxazosin—Nausea—Dexamethasone—multiple sclerosis	0.000159	0.000449	CcSEcCtD
Doxazosin—Nausea—Betamethasone—multiple sclerosis	0.000159	0.000449	CcSEcCtD
Doxazosin—Urticaria—Methotrexate—multiple sclerosis	0.000155	0.000437	CcSEcCtD
Doxazosin—Dizziness—Prednisone—multiple sclerosis	0.000154	0.000435	CcSEcCtD
Doxazosin—Body temperature increased—Methotrexate—multiple sclerosis	0.000154	0.000434	CcSEcCtD
Doxazosin—Abdominal pain—Methotrexate—multiple sclerosis	0.000154	0.000434	CcSEcCtD
Doxazosin—Vomiting—Prednisone—multiple sclerosis	0.000148	0.000418	CcSEcCtD
Doxazosin—Rash—Prednisone—multiple sclerosis	0.000147	0.000415	CcSEcCtD
Doxazosin—Dermatitis—Prednisone—multiple sclerosis	0.000147	0.000414	CcSEcCtD
Doxazosin—Headache—Prednisone—multiple sclerosis	0.000146	0.000412	CcSEcCtD
Doxazosin—Hypersensitivity—Methotrexate—multiple sclerosis	0.000144	0.000405	CcSEcCtD
Doxazosin—Asthenia—Methotrexate—multiple sclerosis	0.00014	0.000394	CcSEcCtD
Doxazosin—Nausea—Prednisone—multiple sclerosis	0.000138	0.000391	CcSEcCtD
Doxazosin—Pruritus—Methotrexate—multiple sclerosis	0.000138	0.000389	CcSEcCtD
Doxazosin—Diarrhoea—Methotrexate—multiple sclerosis	0.000133	0.000376	CcSEcCtD
Doxazosin—Dizziness—Methotrexate—multiple sclerosis	0.000129	0.000363	CcSEcCtD
Doxazosin—Vomiting—Methotrexate—multiple sclerosis	0.000124	0.000349	CcSEcCtD
Doxazosin—Rash—Methotrexate—multiple sclerosis	0.000123	0.000347	CcSEcCtD
Doxazosin—Dermatitis—Methotrexate—multiple sclerosis	0.000123	0.000346	CcSEcCtD
Doxazosin—Headache—Methotrexate—multiple sclerosis	0.000122	0.000344	CcSEcCtD
Doxazosin—Nausea—Methotrexate—multiple sclerosis	0.000116	0.000326	CcSEcCtD
Doxazosin—ADRA1A—GPCR downstream signaling—CXCR3—multiple sclerosis	5.43e-05	0.000483	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—GPR65—multiple sclerosis	5.41e-05	0.000482	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—CXCL10—multiple sclerosis	5.41e-05	0.000481	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—CCR2—multiple sclerosis	5.4e-05	0.000481	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—GPC5—multiple sclerosis	5.39e-05	0.00048	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—RRM1—multiple sclerosis	5.34e-05	0.000475	CbGpPWpGaD
Doxazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	5.32e-05	0.000473	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—CCL3—multiple sclerosis	5.31e-05	0.000472	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—POMC—multiple sclerosis	5.3e-05	0.000472	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—CCR2—multiple sclerosis	5.28e-05	0.00047	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—PTGER4—multiple sclerosis	5.23e-05	0.000465	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—CCL2—multiple sclerosis	5.19e-05	0.000461	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—CCL5—multiple sclerosis	5.13e-05	0.000456	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—PTGER4—multiple sclerosis	5.11e-05	0.000454	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—RGS1—multiple sclerosis	5.07e-05	0.000451	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—CXCR3—multiple sclerosis	5.05e-05	0.000449	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	5e-05	0.000444	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	5e-05	0.000444	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—CNR1—multiple sclerosis	4.99e-05	0.000444	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CCR1—multiple sclerosis	4.95e-05	0.000441	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CXCL13—multiple sclerosis	4.95e-05	0.000441	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—CXCL10—multiple sclerosis	4.94e-05	0.00044	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—IL2RA—multiple sclerosis	4.93e-05	0.000439	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—CXCR3—multiple sclerosis	4.93e-05	0.000439	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—CCL3—multiple sclerosis	4.93e-05	0.000439	CbGpPWpGaD
Doxazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	4.92e-05	0.000438	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—CCR2—multiple sclerosis	4.91e-05	0.000437	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.88e-05	0.000434	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—CNR1—multiple sclerosis	4.88e-05	0.000434	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CYP27B1—multiple sclerosis	4.88e-05	0.000434	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CYP24A1—multiple sclerosis	4.88e-05	0.000434	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—GPR65—multiple sclerosis	4.81e-05	0.000428	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—CCR2—multiple sclerosis	4.8e-05	0.000427	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PTGER4—multiple sclerosis	4.75e-05	0.000422	CbGpPWpGaD
Doxazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	4.72e-05	0.00042	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RGS1—multiple sclerosis	4.71e-05	0.000419	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—POMC—multiple sclerosis	4.71e-05	0.000419	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—CCL5—multiple sclerosis	4.66e-05	0.000414	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—CCR5—multiple sclerosis	4.62e-05	0.000411	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—CCL2—multiple sclerosis	4.61e-05	0.00041	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	4.59e-05	0.000409	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	4.59e-05	0.000409	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—CXCR3—multiple sclerosis	4.58e-05	0.000408	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GPC5—multiple sclerosis	4.57e-05	0.000407	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—IL2RA—multiple sclerosis	4.55e-05	0.000405	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—CNR1—multiple sclerosis	4.53e-05	0.000403	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—CXCL10—multiple sclerosis	4.49e-05	0.000399	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—GPR65—multiple sclerosis	4.47e-05	0.000398	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GPC5—multiple sclerosis	4.46e-05	0.000397	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—CCR2—multiple sclerosis	4.46e-05	0.000397	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—CNR1—multiple sclerosis	4.43e-05	0.000394	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CXCL13—multiple sclerosis	4.4e-05	0.000391	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CCR1—multiple sclerosis	4.4e-05	0.000391	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—CXCL10—multiple sclerosis	4.39e-05	0.000391	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	4.38e-05	0.000389	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—POMC—multiple sclerosis	4.38e-05	0.000389	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	4.29e-05	0.000382	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—CCL2—multiple sclerosis	4.28e-05	0.000381	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—CCL5—multiple sclerosis	4.25e-05	0.000379	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CCL3—multiple sclerosis	4.25e-05	0.000378	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GPC5—multiple sclerosis	4.2e-05	0.000374	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—CCR5—multiple sclerosis	4.19e-05	0.000373	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—IL2RA—multiple sclerosis	4.13e-05	0.000368	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—CNR1—multiple sclerosis	4.11e-05	0.000366	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PTGER4—multiple sclerosis	4.09e-05	0.000364	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CXCL13—multiple sclerosis	4.09e-05	0.000364	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCR1—multiple sclerosis	4.09e-05	0.000364	CbGpPWpGaD
Doxazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	4.09e-05	0.000363	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—CXCL10—multiple sclerosis	4.08e-05	0.000363	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PGR—multiple sclerosis	4.03e-05	0.000359	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—CXCL10—multiple sclerosis	3.99e-05	0.000355	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CXCR3—multiple sclerosis	3.95e-05	0.000352	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CD28—multiple sclerosis	3.92e-05	0.000348	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—CCL5—multiple sclerosis	3.86e-05	0.000344	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CCR2—multiple sclerosis	3.84e-05	0.000342	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—CCR5—multiple sclerosis	3.83e-05	0.000341	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—RRM1—multiple sclerosis	3.79e-05	0.000337	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—CCL5—multiple sclerosis	3.78e-05	0.000336	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—IL2RA—multiple sclerosis	3.78e-05	0.000336	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—CXCL10—multiple sclerosis	3.7e-05	0.00033	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—RRM1—multiple sclerosis	3.7e-05	0.000329	CbGpPWpGaD
Doxazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	3.63e-05	0.000323	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—POMC—multiple sclerosis	3.61e-05	0.000321	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—ALB—multiple sclerosis	3.57e-05	0.000317	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CNR1—multiple sclerosis	3.55e-05	0.000316	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CCL3—multiple sclerosis	3.53e-05	0.000314	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—CCL5—multiple sclerosis	3.51e-05	0.000312	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—RRM1—multiple sclerosis	3.48e-05	0.00031	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—CCR5—multiple sclerosis	3.48e-05	0.00031	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—CCL5—multiple sclerosis	3.43e-05	0.000305	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—IL2RA—multiple sclerosis	3.43e-05	0.000305	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	3.41e-05	0.000303	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—CCR5—multiple sclerosis	3.4e-05	0.000303	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	3.4e-05	0.000303	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PTGER4—multiple sclerosis	3.4e-05	0.000302	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—IL2RA—multiple sclerosis	3.36e-05	0.000299	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PGR—multiple sclerosis	3.34e-05	0.000298	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	3.34e-05	0.000297	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CXCR3—multiple sclerosis	3.28e-05	0.000292	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—POMC—multiple sclerosis	3.28e-05	0.000292	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CD28—multiple sclerosis	3.25e-05	0.000289	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—CCL2—multiple sclerosis	3.21e-05	0.000285	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CXCL10—multiple sclerosis	3.19e-05	0.000284	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CCR2—multiple sclerosis	3.19e-05	0.000284	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—CCL5—multiple sclerosis	3.19e-05	0.000284	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	3.18e-05	0.000283	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—CCR5—multiple sclerosis	3.16e-05	0.000281	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CCL3—multiple sclerosis	3.13e-05	0.000279	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—IL2RA—multiple sclerosis	3.12e-05	0.000277	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—CCR5—multiple sclerosis	3.09e-05	0.000275	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—BCHE—multiple sclerosis	3.07e-05	0.000273	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—IL2RA—multiple sclerosis	3.05e-05	0.000271	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PTGER4—multiple sclerosis	3.02e-05	0.000268	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—POMC—multiple sclerosis	3e-05	0.000267	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PGR—multiple sclerosis	2.97e-05	0.000264	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CNR1—multiple sclerosis	2.94e-05	0.000262	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.94e-05	0.000261	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CXCR3—multiple sclerosis	2.91e-05	0.000259	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—TYK2—multiple sclerosis	2.91e-05	0.000259	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCL3—multiple sclerosis	2.91e-05	0.000259	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—IL2—multiple sclerosis	2.89e-05	0.000257	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CD28—multiple sclerosis	2.89e-05	0.000257	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—CCR5—multiple sclerosis	2.87e-05	0.000256	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CCR2—multiple sclerosis	2.83e-05	0.000252	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—IL2RA—multiple sclerosis	2.83e-05	0.000252	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PTGER4—multiple sclerosis	2.8e-05	0.000249	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CD86—multiple sclerosis	2.79e-05	0.000249	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PGR—multiple sclerosis	2.76e-05	0.000246	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CCL5—multiple sclerosis	2.75e-05	0.000245	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—POMC—multiple sclerosis	2.72e-05	0.000242	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CXCR3—multiple sclerosis	2.71e-05	0.000241	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CD28—multiple sclerosis	2.68e-05	0.000239	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—IL2—multiple sclerosis	2.67e-05	0.000237	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—CCL2—multiple sclerosis	2.66e-05	0.000237	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—POMC—multiple sclerosis	2.66e-05	0.000237	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CXCL10—multiple sclerosis	2.65e-05	0.000236	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCR2—multiple sclerosis	2.63e-05	0.000234	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CNR1—multiple sclerosis	2.62e-05	0.000233	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—SPP1—multiple sclerosis	2.55e-05	0.000227	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.52e-05	0.000225	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CCR5—multiple sclerosis	2.48e-05	0.00022	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—POMC—multiple sclerosis	2.47e-05	0.00022	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL2RA—multiple sclerosis	2.44e-05	0.000217	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CNR1—multiple sclerosis	2.43e-05	0.000216	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—IL2—multiple sclerosis	2.42e-05	0.000216	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—TYK2—multiple sclerosis	2.42e-05	0.000215	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—POMC—multiple sclerosis	2.42e-05	0.000215	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—CCL2—multiple sclerosis	2.36e-05	0.00021	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CXCL10—multiple sclerosis	2.36e-05	0.00021	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CD86—multiple sclerosis	2.32e-05	0.000206	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.3e-05	0.000205	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CCL5—multiple sclerosis	2.28e-05	0.000203	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—TGFB1—multiple sclerosis	2.26e-05	0.000201	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—APOE—multiple sclerosis	2.25e-05	0.000201	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—POMC—multiple sclerosis	2.25e-05	0.0002	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—IL2—multiple sclerosis	2.21e-05	0.000197	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—MAPK1—multiple sclerosis	2.21e-05	0.000197	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—CCL2—multiple sclerosis	2.2e-05	0.000195	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CXCL10—multiple sclerosis	2.19e-05	0.000195	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—BCHE—multiple sclerosis	2.17e-05	0.000193	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	2.15e-05	0.000191	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.14e-05	0.00019	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—BCHE—multiple sclerosis	2.12e-05	0.000189	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SPP1—multiple sclerosis	2.11e-05	0.000188	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	2.06e-05	0.000183	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CCR5—multiple sclerosis	2.06e-05	0.000183	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CD80—multiple sclerosis	2.04e-05	0.000181	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	2.03e-05	0.00018	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL2RA—multiple sclerosis	2.03e-05	0.00018	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—IL2—multiple sclerosis	2.01e-05	0.000179	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—BCHE—multiple sclerosis	2e-05	0.000178	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—TYK2—multiple sclerosis	1.99e-05	0.000177	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	1.97e-05	0.000175	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—POMC—multiple sclerosis	1.94e-05	0.000172	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	1.91e-05	0.00017	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CCL2—multiple sclerosis	1.89e-05	0.000169	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	1.88e-05	0.000168	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	1.88e-05	0.000167	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—APOE—multiple sclerosis	1.87e-05	0.000166	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—MAPK1—multiple sclerosis	1.85e-05	0.000165	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—APOE—multiple sclerosis	1.85e-05	0.000164	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	1.83e-05	0.000163	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	1.83e-05	0.000163	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	1.8e-05	0.00016	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	1.79e-05	0.000159	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	1.74e-05	0.000155	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TYK2—multiple sclerosis	1.72e-05	0.000153	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	1.7e-05	0.000151	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CD80—multiple sclerosis	1.69e-05	0.00015	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	1.67e-05	0.000149	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	1.66e-05	0.000148	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	1.66e-05	0.000148	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—POMC—multiple sclerosis	1.61e-05	0.000143	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—POMC—multiple sclerosis	1.59e-05	0.000141	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	1.57e-05	0.00014	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	1.54e-05	0.000137	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	1.54e-05	0.000137	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	1.5e-05	0.000134	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—ALB—multiple sclerosis	1.45e-05	0.000129	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL2—multiple sclerosis	1.43e-05	0.000127	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	1.43e-05	0.000127	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	1.43e-05	0.000127	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—IL6—multiple sclerosis	1.42e-05	0.000127	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	1.4e-05	0.000124	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	1.4e-05	0.000124	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	1.37e-05	0.000122	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MMP9—multiple sclerosis	1.35e-05	0.000121	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	1.33e-05	0.000118	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—APOE—multiple sclerosis	1.31e-05	0.000116	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	1.3e-05	0.000115	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—APOE—multiple sclerosis	1.28e-05	0.000114	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	1.27e-05	0.000113	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	1.27e-05	0.000113	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—STAT3—multiple sclerosis	1.2e-05	0.000107	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—APOE—multiple sclerosis	1.2e-05	0.000107	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	1.19e-05	0.000106	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	1.18e-05	0.000105	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	1.18e-05	0.000105	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	1.12e-05	0.0001	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—POMC—multiple sclerosis	1.12e-05	0.0001	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MYC—multiple sclerosis	1.12e-05	9.96e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TGFB1—multiple sclerosis	1.12e-05	9.93e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—POMC—multiple sclerosis	1.1e-05	9.76e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MAPK1—multiple sclerosis	1.1e-05	9.74e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	1.06e-05	9.39e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	1.05e-05	9.34e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—POMC—multiple sclerosis	1.03e-05	9.2e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ALB—multiple sclerosis	1.02e-05	9.12e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ALB—multiple sclerosis	1e-05	8.9e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	1e-05	8.9e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	9.99e-06	8.89e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	9.81e-06	8.72e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	9.76e-06	8.68e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ALB—multiple sclerosis	9.42e-06	8.38e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	9.29e-06	8.27e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	9.28e-06	8.26e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	9.27e-06	8.25e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	9.09e-06	8.09e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	8.88e-06	7.9e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL6—multiple sclerosis	8.41e-06	7.49e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	8.25e-06	7.34e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	8.25e-06	7.34e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	8.23e-06	7.32e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	8.07e-06	7.18e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	7.67e-06	6.82e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	7.65e-06	6.8e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	7.5e-06	6.67e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	6.98e-06	6.21e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	6.2e-06	5.52e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	5.76e-06	5.13e-05	CbGpPWpGaD
